Gene knockdown of PCTAIRE1 sensitized several prostate and breast cancer cells to TNF-family cytokines, whereas PCTAIRE1-knockdown did not sensitize normal or non-transformed cells to TRAIL. This evidence concerns the gene CDK16 and breast carcinoma.